Request Discount

Cardiac Ablation Market (Types - Catheter Ablation, Hybrid Surgical-catheter Ablation, and Surgical Ablation; Application - Cardiac Rhythm Management, Open Surgery, and Other Applications; End User - Hospitals, Ambulatory Surgical Centers, and Specialty Clinics): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : June, 2019

  • Rep Id : HC0532

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Cardiac Ablation Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Cardiac Ablation Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Cardiac Ablation Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on cardiac ablation market provides in-depth analysis of segments and sub-segments in the global as well as regional cardiac ablation market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cardiac ablation market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cardiac ablation market. According to the report, the global cardiac ablation market is projected to grow at a CAGR of 12.4% over the forecast period of 2019-2025.

Global Cardiac Ablation Market


Market Insight

Cardiac ablation is a procedure used to destroy tissue in the heart that lets incorrect electrical signals to cause an abnormal heart rhythm. This technique is commonly used for treating cardiac arrhythmia such as cardiac arrhythmias such as atrial flutter, atrial fibrillation, supraventricular tachycardia, and Wolff-Parkinson-White syndrome. Cardiac ablation is a non-invasive method. The most common method is using a catheter, they are inserted in the body. Cardiac ablation for arrhythmia offers long term care and high success rates. Cardiac ablation delivers 90 to 98 percent success rate in arrhythmia patients.


The rising occurrence of the cardiac arrhythmia around the world is driving the growth of cardiac ablation market. Atrial fibrillation is a precursor to a number of serious cardiovascular complications, including stroke. As many as 2.2 million Americans are living with atrial fibrillation. A recent study has suggested that 1 in 4 Adult Americans over the age of 40 could develop an irregular heartbeat. Therefore, an increased risk of irregular heartbeat disorders among the rising geriatric population also propels the market growth. Furthermore, open heart surgeries and stretched drug therapies are being replaced with cardiac ablation as it is minimally invasive and inexpensive as compared to other medical therapies. In addition, patient recovery is also fast in cardiac ablation procedures. The major restraint for cardiac ablation market is a lack of trained professionals. Moreover, increasing approvals from regulatory bodies for new technological advancements are providing favorable opportunities for the growth of cardiac ablation market.


Among the regions, North America holds the major market share in the cardiac ablation market. The high adoption of minimally invasive medical procedures and the growing application of cardiac ablation market in the healthcare sector are projected to contribute to the growth of the cardiac ablation market technology market across North America. The Asia Pacific is estimated to grow at the fastest rate owing to the growth of cardiovascular disease, rising preference for minimally invasive surgical procedures and increasing spending capacity on healthcare in this region. Furthermore, the growth of medical tourism in Asian countries such as China, Japan, and India favors the growth of the Asia Pacific cardiac ablation market.


Segment Covered

The report on global cardiac ablation market covers segments such as types, application, and end user. On the basis of types, the sub-markets include catheter ablation, hybrid surgical-catheter ablation, and surgical ablation. On the basis of application, the sub-markets include cardiac rhythm management, open surgery, and other applications. On the basis of end user, the sub-markets include hospitals, ambulatory surgical centers, and specialty clinics.


Companies Profiled:

The report provides profiles of the companies in the market such as Abbott Laboratories, Advanced Cardiac Therapeutics, Inc., St. Jude Medical, Inc., Medtronic plc, Olympus Corporation, EPIX Therapeutics, Inc, Biosense Webster, Inc., Boston Scientific Corporation, CONMED Corporation, and AngioDynamics, Inc.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cardiac ablation market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount